The genome editing is expected to be valued at US$ 6.2 billion in 2024. Genome editing is projected to grow at a moderate CAGR of 15.7% from 2024 to 2034. The global genome editing market size is predicted to reach US$ 26.5 billion by 2034.
| Attributes | Key Insights |
|---|---|
| Estimated Market Size in 2024 | US$ 6.2 billion |
| Projected Market Value in 2034 | US$ 26.5 billion |
| Value-based CAGR from 2024 to 2034 | 15.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Genome editing accounted for 18.4% CAGR from 2019 to 2023. Genome editing tools continue to advance in their delivery methods. The efficiency and safety of CRISPR editing were being improved by developing new and improved methods of delivering CRISPR components to target cells.
Personalized and targeted gene therapies for cancer are being explored using genome editing. Cancer cells can be targeted and destroyed by immune cells that have been enhanced to target and destroy them by scientists.
A growing emphasis was placed on public awareness and engagement as genome editing technologies gained traction. In addition to exploring the potential benefits and risks of gene editing, there was also a conversation about the ethical implications. A 15.7% CAGR is forecast between 2024 and 2034.
| Historical CAGR from 2019 to 2023 | 18.4% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 15.7% |
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
According to the table provided, South Korea and the United Kingdom have the highest gene editing market revenue. As genome editing technology develops, it will significantly impact the future of the market.
Biological parts, devices, and systems can be designed and constructed through synthetic biology. This technology enables the development of new gene-editing methods and tools, expanding the application possibilities of genome editing.
Gene-editing tools can be delivered to target cells with increased precision using nanotechnology. Genome editing can be more efficient and safer by engineered nanoparticles that carry gene-editing components.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 15.9% |
| China | 16.2% |
| Japan | 16.5% |
| South Korea | 17.8% |
| The United Kingdom | 17.1% |
A high demand for genome editing is expected in the United States. A CAGR of 15.9% is forecast for the market during the period. Regulatory scrutiny of genome editing technologies, particularly those that may be applied to human therapeutic applications, has been conducted by agencies such as the Food and Drug Administration (FDA).
The United States witnessed several ongoing ethical debates, especially regarding the use of germline editing, as well as the use of genome editing in humans. Technology advancements and an expanding hospital infrastructure are expected to increase the demand for genome editing in the United States.
China is predicted to have a growing market for genome editing. The growth rate is expected to be 16.2% between 2024 and 2034. The market is expected to reach US$ 4.2 billion by 2034. The government has contributed significantly to genome editing research and biotech development, fostering innovation and accelerating technology development.
China has dominated research and development in genome editing. Regulations have been implemented to regulate gene editing in humans, though concerns remain about regulating private ventures. A call for stricter regulations and international cooperation has arisen in response to ethical concerns regarding gene editing.
Japan is expected to lead the market for genome editing market. A 16.5% CAGR is predicted for the market during the forecast period. By 2034, the market is expected to generate US$ 2.8 billion in revenues. Biotechnology is one of Japan's most advanced fields. Several technological advances have contributed to the growth of genome editing in Japan.
Age-related diseases are among the top medical innovations in Japan, which is one of the world's most rapidly aging populations. A growing interest in genome editing in Japan is driven by its potential to develop personalized treatments for diseases caused by aging.
Research and development in genome editing has been a major focus of South Korea, contributing significantly to the field. A market growth of US$ 1.6 billion is anticipated by 2034. South Korea has conducted extensive research into genome editing. Using CRISPR-Cas9 gene scissors and other gene-editing technologies, the country has been actively involved in developing and applying gene-editing technologies.
Several biotech companies in South Korea specialize in genome editing technologies. The products or services provided by some companies include new therapies, gene editing, and agricultural applications. The biotechnology industry in South Korea is highly competitive, and it places great importance on research and development. South Korea invests heavily in cutting-edge technologies that promote growth and innovation as part of its initiatives to maintain its competitiveness globally.
Many renowned universities and research institutions throughout the United Kingdom are actively involved in genome editing research. Research from these institutions is often relevant to medicine and agriculture and contributes to the advancement of the field.
The regulatory environment heavily influences genome editing market dynamics in the United Kingdom. A policy to balance ethical and safety considerations with innovation is being developed in the United Kingdom with respect to genome editing regulations. The United Kingdom is actively researching genetic disorders and clinical trials using genome editing techniques.
A CAGR of 17.1% is projected for the United Kingdom between 2024 and 2034. Government initiatives, private investors, and international collaborations have all invested in and funded the genome editing industry in the United Kingdom.
This section illustrates the market's leading segment. Based on the technology, the meganucleases segment is expected to expand at a CAGR of 15.6% by 2034. Based on the delivery, the ex-vivo segment is expected to expand at a CAGR of 15.3% by 2034.
| Category | CAGR from 2024 to 2034 |
|---|---|
| Meganucleases | 15.6% |
| Ex-vivo | 15.3% |
A meganuclease's ability to recognize and cut specific DNA sequences is highly precise. By 2034, the meganucleas sector is forecasted to record a CAGR of 15.6%. As a result of their specificity, they can be used for targeted genome editing with minimal off-target effects.
Genome editing and repair can be achieved with meganuclease by inducing homologous recombination. Inactivation of specific genes can be achieved using meganuclease’s that cut and target DNA sequences. For example, CCR5, an important HIV receptor, has been targeted by meganuclease in clinical trials.
Ex CRISPR-Cas9, zinc finger nucleases (ZFNs), or transcription activator-like effector nucleases (TALENs) are among the tools that can be introduced into cells for vivo genome editing. Infecting cells with viruses, electroporation, and lipids can all be accomplished this way, with a variety of techniques available for each.
The ex-vivo market is predicted to expand at a CAGR of 15.3% through 2034. In addition to treating genetic disorders and cancer, ex vivo genome editing is also effective against certain viral infections. Mutations in DNA may be corrected, immune response enhanced, or therapeutic genes may be introduced by altering the genetic material of cells.
The manufacturers of genome editing tools are seeking strategic partnerships and collaborations with other companies to expand their research capabilities. Research and development activities by several market players are leading to innovations in genetic testing.
Key Market Developments
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 6.2 billion |
| Projected Market Valuation in 2034 | US$ 26.5 billion |
| Value-based CAGR 2024 to 2034 | 15.7% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ billion |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
As of 2024, the genome editing market is expected to be valued at US$ 6.2 billion.
By 2034, the market value of genome editing is expected to reach US$ 26.5 billion.
From 2024 to 2034, genome editing is expected to flourish at a CAGR of 15.7%
The meganucleases segment is expected to increase at 15.6% CAGR by 2034.
South Korea is expected to hold the largest market, with a CAGR of 17.8%.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2024 to 2034
5.3.1. Meganucleases
5.3.2. (CRISPR)/Cas9
5.3.3. TALENs/MegaTALs
5.3.4. ZFN
5.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Delivery
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Delivery, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Delivery, 2024 to 2034
6.3.1. Ex-vivo
6.3.2. In-vivo
6.4. Y-o-Y Growth Trend Analysis By Delivery, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Delivery, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Mode
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Mode, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mode, 2024 to 2034
7.3.1. Contract
7.3.2. In-house
7.4. Y-o-Y Growth Trend Analysis By Mode, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Mode, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2019 to 2023
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2024 to 2034
8.3.1. Biotechnology & Pharmaceutical Companies
8.3.2. Academic & Government Research Institutes
8.3.3. Contract Research Organizations
8.4. Y-o-Y Growth Trend Analysis By End-use, 2019 to 2023
8.5. Absolute $ Opportunity Analysis By End-use, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
9.3.1. Genetic Engineering
9.3.1.1. Cell Line Engineering
9.3.1.2. Animal Genetic Engineering
9.3.1.3. Plant Genetic Engineering
9.3.1.4. Others
9.3.2. Clinical Applications
9.3.2.1. Diagnostics
9.3.2.2. Therapy Development
9.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
9.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. South Asia and Pacific
10.3.6. East Asia
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. USA
11.2.1.2. Canada
11.2.2. By Technology
11.2.3. By Delivery
11.2.4. By Mode
11.2.5. By End-use
11.2.6. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Technology
11.3.3. By Delivery
11.3.4. By Mode
11.3.5. By End-use
11.3.6. By Application
11.4. Key Takeaways
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Technology
12.2.3. By Delivery
12.2.4. By Mode
12.2.5. By End-use
12.2.6. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Technology
12.3.3. By Delivery
12.3.4. By Mode
12.3.5. By End-use
12.3.6. By Application
12.4. Key Takeaways
13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. UK
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Technology
13.2.3. By Delivery
13.2.4. By Mode
13.2.5. By End-use
13.2.6. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Technology
13.3.3. By Delivery
13.3.4. By Mode
13.3.5. By End-use
13.3.6. By Application
13.4. Key Takeaways
14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. Poland
14.2.1.2. Russia
14.2.1.3. Czech Republic
14.2.1.4. Romania
14.2.1.5. Rest of Eastern Europe
14.2.2. By Technology
14.2.3. By Delivery
14.2.4. By Mode
14.2.5. By End-use
14.2.6. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Technology
14.3.3. By Delivery
14.3.4. By Mode
14.3.5. By End-use
14.3.6. By Application
14.4. Key Takeaways
15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Bangladesh
15.2.1.3. Australia
15.2.1.4. New Zealand
15.2.1.5. Rest of South Asia and Pacific
15.2.2. By Technology
15.2.3. By Delivery
15.2.4. By Mode
15.2.5. By End-use
15.2.6. By Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Technology
15.3.3. By Delivery
15.3.4. By Mode
15.3.5. By End-use
15.3.6. By Application
15.4. Key Takeaways
16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
16.2.1. By Country
16.2.1.1. China
16.2.1.2. Japan
16.2.1.3. South Korea
16.2.2. By Technology
16.2.3. By Delivery
16.2.4. By Mode
16.2.5. By End-use
16.2.6. By Application
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Technology
16.3.3. By Delivery
16.3.4. By Mode
16.3.5. By End-use
16.3.6. By Application
16.4. Key Takeaways
17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Israel
17.2.1.4. Rest of MEA
17.2.2. By Technology
17.2.3. By Delivery
17.2.4. By Mode
17.2.5. By End-use
17.2.6. By Application
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Technology
17.3.3. By Delivery
17.3.4. By Mode
17.3.5. By End-use
17.3.6. By Application
17.4. Key Takeaways
18. Key Countries Market Analysis
18.1. USA
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2023
18.1.2.1. By Technology
18.1.2.2. By Delivery
18.1.2.3. By Mode
18.1.2.4. By End-use
18.1.2.5. By Application
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2023
18.2.2.1. By Technology
18.2.2.2. By Delivery
18.2.2.3. By Mode
18.2.2.4. By End-use
18.2.2.5. By Application
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2023
18.3.2.1. By Technology
18.3.2.2. By Delivery
18.3.2.3. By Mode
18.3.2.4. By End-use
18.3.2.5. By Application
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2023
18.4.2.1. By Technology
18.4.2.2. By Delivery
18.4.2.3. By Mode
18.4.2.4. By End-use
18.4.2.5. By Application
18.5. Germany
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2023
18.5.2.1. By Technology
18.5.2.2. By Delivery
18.5.2.3. By Mode
18.5.2.4. By End-use
18.5.2.5. By Application
18.6. UK
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2023
18.6.2.1. By Technology
18.6.2.2. By Delivery
18.6.2.3. By Mode
18.6.2.4. By End-use
18.6.2.5. By Application
18.7. France
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2023
18.7.2.1. By Technology
18.7.2.2. By Delivery
18.7.2.3. By Mode
18.7.2.4. By End-use
18.7.2.5. By Application
18.8. Spain
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2023
18.8.2.1. By Technology
18.8.2.2. By Delivery
18.8.2.3. By Mode
18.8.2.4. By End-use
18.8.2.5. By Application
18.9. Italy
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2023
18.9.2.1. By Technology
18.9.2.2. By Delivery
18.9.2.3. By Mode
18.9.2.4. By End-use
18.9.2.5. By Application
18.10. Poland
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2023
18.10.2.1. By Technology
18.10.2.2. By Delivery
18.10.2.3. By Mode
18.10.2.4. By End-use
18.10.2.5. By Application
18.11. Russia
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2023
18.11.2.1. By Technology
18.11.2.2. By Delivery
18.11.2.3. By Mode
18.11.2.4. By End-use
18.11.2.5. By Application
18.12. Czech Republic
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2023
18.12.2.1. By Technology
18.12.2.2. By Delivery
18.12.2.3. By Mode
18.12.2.4. By End-use
18.12.2.5. By Application
18.13. Romania
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2023
18.13.2.1. By Technology
18.13.2.2. By Delivery
18.13.2.3. By Mode
18.13.2.4. By End-use
18.13.2.5. By Application
18.14. India
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2023
18.14.2.1. By Technology
18.14.2.2. By Delivery
18.14.2.3. By Mode
18.14.2.4. By End-use
18.14.2.5. By Application
18.15. Bangladesh
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2023
18.15.2.1. By Technology
18.15.2.2. By Delivery
18.15.2.3. By Mode
18.15.2.4. By End-use
18.15.2.5. By Application
18.16. Australia
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2023
18.16.2.1. By Technology
18.16.2.2. By Delivery
18.16.2.3. By Mode
18.16.2.4. By End-use
18.16.2.5. By Application
18.17. New Zealand
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2023
18.17.2.1. By Technology
18.17.2.2. By Delivery
18.17.2.3. By Mode
18.17.2.4. By End-use
18.17.2.5. By Application
18.18. China
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2023
18.18.2.1. By Technology
18.18.2.2. By Delivery
18.18.2.3. By Mode
18.18.2.4. By End-use
18.18.2.5. By Application
18.19. Japan
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2023
18.19.2.1. By Technology
18.19.2.2. By Delivery
18.19.2.3. By Mode
18.19.2.4. By End-use
18.19.2.5. By Application
18.20. South Korea
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2023
18.20.2.1. By Technology
18.20.2.2. By Delivery
18.20.2.3. By Mode
18.20.2.4. By End-use
18.20.2.5. By Application
18.21. GCC Countries
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2023
18.21.2.1. By Technology
18.21.2.2. By Delivery
18.21.2.3. By Mode
18.21.2.4. By End-use
18.21.2.5. By Application
18.22. South Africa
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2023
18.22.2.1. By Technology
18.22.2.2. By Delivery
18.22.2.3. By Mode
18.22.2.4. By End-use
18.22.2.5. By Application
18.23. Israel
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2023
18.23.2.1. By Technology
18.23.2.2. By Delivery
18.23.2.3. By Mode
18.23.2.4. By End-use
18.23.2.5. By Application
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Technology
19.3.3. By Delivery
19.3.4. By Mode
19.3.5. By End-use
19.3.6. By Application
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. Merck KGaA
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.2. Cibus, Recombinetics, Inc.
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.3. Sangamo
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.4. Editas Medicine
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.5. Precision Biosciences
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.6. CRISPR Therapeutics
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.7. Intellia Therapeutics, Inc.
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.8. Caribou Biosciences, Inc.
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.9. Cellectis S.A.
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.10. AstraZeneca
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
20.1.11. Takara Bio USA
20.1.11.1. Overview
20.1.11.2. Product Portfolio
20.1.11.3. Profitability by Market Segments
20.1.11.4. Sales Footprint
20.1.11.5. Strategy Overview
20.1.11.5.1. Marketing Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Genome Editing Market
